Can I read Aspirin or P2Y12 Inhibitor Monotherapy em DAC ESC Nov 2025 on EtoBox?

Aspirin or P2Y12 Inhibitor Monotherapy em DAC ESC Nov 2025 by Luiz Minuzzo is a document available to read on EtoBox.

What is Aspirin or P2Y12 Inhibitor Monotherapy em DAC ESC Nov 2025 about?

This review examines the efficacy and safety of aspirin versus P2Y12 inhibitors for long-term antiplatelet therapy in patients with atherosclerotic cardiovascular disease (ASCVD). While aspirin has been the traditional choice, emerging evidence suggests that P2Y12 inhibitors may offer superior benefits, particularly in reducing cardiovascular events. The article discusses practical considerations, including variability in drug response and side effects, to aid clinicians in optimizing treatment strategies f

Author

Luiz Minuzzo

Language

EN